PAREXEL International Corporation (NASDAQ:PRXL) was the target of a large growth in short interest in the month of August. As of August 15th, there was short interest totalling 993,145 shares, a growth of 96.0% from the July 31st total of 506,636 shares. Approximately 2.0% of the company’s stock are short sold. Based on an average daily volume of 603,829 shares, the short-interest ratio is currently 1.6 days.

A number of research analysts have commented on PRXL shares. Zacks Investment Research downgraded shares of PAREXEL International Corporation from a “hold” rating to a “sell” rating in a research report on Saturday, May 6th. Evercore ISI raised shares of PAREXEL International Corporation from an “in-line” rating to an “outperform” rating and set a $85.00 target price on the stock in a research report on Monday, May 15th. Goldman Sachs Group, Inc. (The) raised shares of PAREXEL International Corporation from a “sell” rating to a “neutral” rating and raised their target price for the company from $63.00 to $77.00 in a research report on Tuesday, May 23rd. Barclays PLC reissued an “overweight” rating and set a $87.00 target price on shares of PAREXEL International Corporation in a research report on Wednesday, May 17th. Finally, Credit Suisse Group reissued a “neutral” rating and set a $83.00 target price (up previously from $65.00) on shares of PAREXEL International Corporation in a research report on Tuesday, June 6th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the company’s stock. PAREXEL International Corporation has a consensus rating of “Hold” and an average target price of $75.93.

PAREXEL International Corporation (NASDAQ PRXL) opened at 87.70 on Monday. The stock has a 50 day moving average of $87.51 and a 200-day moving average of $75.37. PAREXEL International Corporation has a 12 month low of $51.16 and a 12 month high of $87.86. The stock has a market cap of $4.45 billion, a P/E ratio of 38.55 and a beta of 0.79.

A number of large investors have recently bought and sold shares of the company. Capstone Asset Management Co. increased its stake in shares of PAREXEL International Corporation by 3.8% in the first quarter. Capstone Asset Management Co. now owns 4,409 shares of the medical research company’s stock worth $278,000 after buying an additional 160 shares during the period. Clinton Group Inc. purchased a new stake in shares of PAREXEL International Corporation during the first quarter worth $3,682,000. Macquarie Group Ltd. purchased a new stake in shares of PAREXEL International Corporation during the fourth quarter worth $789,000. LSV Asset Management increased its stake in shares of PAREXEL International Corporation by 43.9% in the first quarter. LSV Asset Management now owns 380,751 shares of the medical research company’s stock worth $24,029,000 after buying an additional 116,200 shares during the period. Finally, Gabelli Funds LLC purchased a new stake in shares of PAREXEL International Corporation during the first quarter worth $1,136,000. Institutional investors own 91.58% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was originally posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://theolympiareport.com/2017/08/28/parexel-international-corporation-prxl-short-interest-update.html.

About PAREXEL International Corporation

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.

Receive News & Ratings for PAREXEL International Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.